Cowen Inc’s Novavax NVAX Stock Holding History

Cowen Inc’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,300	Closed	-$54K	–	523
2019 Q1	$54K	Buy	+3,300	New	+$104K	0.01%	266
2016 Q4	–	Sell	-5,015	Closed	-$208K	–	286
2016 Q3	$208K	Buy	+5,015	New	+$647K	0.01%	211

Other funds holding NVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cowen Inc's NVAX Position: Q4 2016 in Review

Cowen Inc sold out of Novavax (NVAX) in Q4 2016, closing a stake of 5,015 shares — an estimated $209K sold.

Cowen Inc first reported a position in NVAX in Q1 2016 and held it in 2 quarters. The position peaked at $209K in Q3 2016. 143 funds tracked by Wall St. Rank hold NVAX as of Q4 2016.

Cowen Inc reported no remaining Novavax position as of Q4 2016 after selling out during the quarter.
Cowen Inc sold 5,015 Novavax shares in Q4 2016, an estimated $209K.
Cowen Inc first reported a position in Novavax in Q1 2016 and held it in 2 quarters.
Cowen Inc's Novavax position peaked at $209K in Q3 2016.
143 funds tracked by Wall St. Rank held Novavax as of Q4 2016.

Based on Cowen Inc's 13F filing for Q4 2016, filed 13 Feb 2017.